GLP-1 weight-loss results vary widely, and eating patterns may help explain why some patients lose more weight than others.

Weight isn’t the only thing GLP-1 users are losing. Two new studies presented Wednesday in Europe found hair loss and nail detachment are more commonly associated with patients taking the blockbuster ...

Before you switch from Wegovy to Zepbound or Ozempic, learn why weight loss plateaus happen and how long you should really ...

An estimated 11% of U.S. adults now take a GLP-1 medication for weight loss, up from 3% in 2024, according to Gallup's 2026 ...

Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults ...

Evidence regarding safety in this population hasn't kept pace, researchers warn ...

Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and ...

The Association of Anaesthetists recommends patients continue their GLP-1 medication during the preoperative period.

High monthly costs lead to over 80% of weight loss patients to stop taking GLP-1 medications.

Understanding why some people see no benefits from potent anti-obesity medications could lead to new therapies and ...

As people flock to GLP-1 drugs, what do consumers need to know about the side effects, risks, benefits, and bonuses?

Chipotle, McDonald's and Shake Shack are among the restaurant chains revamping their menus as more consumers go on ...